U.S. IPO Weekly Recap: IPO Frenzy Brings The Year's Largest Deal And Biggest Pop In A 17 IPO Week

Feb. 14, 2021 11:23 PM ET, , , , , , , , , , , , , , , , , , , , , , , , 1 Comment

Summary

  • The IPO frenzy continued this past week as 17 IPOs and 26 SPACs entered the public market.
  • Headlining the week were dating app Bumble, which completed the year's largest deal so far, and Chinese cloud services provider Cloopen Group, which bagged the biggest pop of 2021 to date.
  • 28 SPACs submitted initial filings, led by Bill Foley's Austerlitz Acquisition I and Austerlitz Acquisition II, which filed to raise $500 million and $1 billion, respectively.

The IPO frenzy continued this past week as 17 IPOs and 26 SPACs entered the public market. Headlining the week were dating app Bumble (BMBL), which completed the year's largest deal so far, and Chinese cloud services provider Cloopen Group (RAAS), which bagged the biggest pop of 2021 to date.

Bumble priced further upsized and priced above the upwardly revised range to raise $2.2 billion at an $8.7 billion market cap. The company operates the Bumble and Badoo apps, the world's second and fourth highest grossing dating apps, respectively. While COVID-19 hurt average revenue per paying user, the company generates strong EBITDA margins, and growth accelerated in the most recent quarter. Bumble finished up 76%.

Cloopen Group Holding priced above the range to raise $320 million at a $2.4 billion market cap, and soared 200% on its first day of trading. Unprofitable with decelerating growth in the 9mo20, the company is China's largest multi-capability cloud-based communications solution provider by 2019 revenue. After its initial jump, Cloopen traded down to finish the week with a 96% return from IPO.

Signify Health (SGFY) priced above the upwardly revised range to raise $564 million at a $5.5 billion market cap. Formed by New Mountain Capital, Signify Health is a value-based healthcare platform primarily supporting Medicare Advantage plans. Benefiting from the shift to value-based care, the company has posted strong growth and EBITDA margins, though its revenue stream is concentrated. Signify finished up 52%.

Advertising software provider Viant Technology (DSP) further upsized and priced above the upwardly revised range to raise $250 million at a $1.6 billion market cap. The company has demonstrated strong growth, and despite declines in customer count and revenue in the 9mo20, it maintained profitability and expanded margins during the pandemic. Viant finished up 162%.

Diagnostic testing developer Talis Biomedical (

This article was written by

Renaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO ETF (NYSE: IPO) and the Renaissance International IPO ETF (NYSE: IPOS). Individual investors can get a free overview of the IPO market on www.renaissancecapital.com, and try a free trial of our premium platform, IPO Pro (ipopro.renaissancecapital.com). Through Renaissance Capital’s pre-IPO research service, institutional investors get an independent opinion, in-depth fundamental analysis, and customizable financial models on all IPOs.

Recommended For You

Related Stocks

SymbolLast Price% Chg
BMBL--
Bumble Inc.
RAAS--
Cloopen Group Holding Limited
CVS--
CVS Health Corporation
DSP--
Viant Technology Inc.
TLIS--
Talis Biomedical Corporation

Related Analysis